Hematology

Risk-adapted Chemo Strategy Proves Effective In Adult Burkitt Lymphoma

(MedPage Today) -- Study Authors: Mark Roschewski, Kieron Dunleavy, et al. Target Audience and Goal Statement: Oncologists, hematologists The goal of this study was to determine if dose-adjusted etoposide, doxorubicin, cyclophosphamide,...
Related topics: Chemotherapy, Cancer, Lymphoma, Medical Research, Oncology

Read More →

Perkinelmer's Tie-up To Boost Health Outcomes In Africa

PerkinElmer, Inc. PKI recently collaborated with the world’s largest professional society of hematologists — American Society of Hematology (“ASH”) — to lend support to an initiative to bolster capacity for newborn...

Read More →

Thrombosis In Covid-19: What We Know And How To Treat

Hematologist Mary Cushman discusses arterial and venous thrombosis issues with SARS-CoV-2 and the role of anticoagulation. theheart.org on Medscape
Related topics: Thrombosis

Read More →

A Pediatric Hematologist Explains Multisystem Inflammatory Syndrome In Children

The recent pandemic has confined people all over the world to the indoors to try to keep the virus from spreading. Older adults have been the most commonly affected age group with the virus, but more recently, a strange presentation of COVID-19 has...
Related topics: Virus, Virology

Read More →

Will A Blood Test Revolutionize Alzheimer's Diagnosis?

(MedPage Today) -- Study Authors: Thomas K. Karikari, Tharick A. Pascoal, et al.; Clifford R. Jack Jr. Target Audience and Goal Statement: Neurologists, hematologists, radiologists The goal of this study was to assess the application of a new...
Related topics: Blood Test, Alzheimer's Disease, Medical Research

Read More →

Anti-cd22 Car T Cells Promising In Youths With B-cell Malignancies

(MedPage Today) -- Study Authors: Nirali N. Shah, Steven L. Highfill, et al. Target Audience and Goal Statement: Oncologists, hematologists, pediatricians The goal of this study was to determine if anti-CD22 chimeric antigen receptor (CAR) T...
Related topics: Medical Research, Cancer, Oncology

Read More →

Reach2 Highlights Efficacy Of Jak1/2 Inhibitor Vs Standard Care For Acute Gvhd

(MedPage Today) -- Study Authors: Robert Zeiser, Nikolas von Bubnoff, et al.; Nelson Chao Target Audience and Goal Statement: Oncologists, hematologists The goal of this study was to determine the benefit/risk profile of the Janus kinase (JAK...
Related topics: Medical Research, Cancer, Oncology

Read More →

Seth Corey: The Pandemic Is Peaking

(Scott Johnson) Dr. Seth Corey is Professor, Pediatrics and Molecular Medicine and on staff in the Departments of Pediatrics, Cancer Biology, and Translational Hematology and Oncology Research at the Cleveland Clinic. He sends along this Facebook...
Related topics: Cancer, Oncology, Medical Research, Facebook, Social Media

Read More →

A.m. Roundup: Cuomo And Lawmakers Reach ‘conceptual Agreement’ On Budget With Key Items Missing

Good morning. Medical staff deserve all the praise: Staff from New York Oncology Hematology teamed up with the Albany Police Department and other first responders on Wednesday to show their support for medical staff and chemotherapy patients....
Related topics: Cancer, Oncology, Police, Chemotherapy

Read More →

Modeling Study Supports Psa-stratified Screening For Prostate Cancer

(MedPage Today) -- Study Authors: Eveline A.M. Heijnsdijk, Roman Gulati, et al. Target Audience and Goal Statement: Oncologists, hematologists, urologists The goal of this study was to determine the benefits and harms of prostate cancer...
Related topics: Medical Research, Prostate Cancer, Cancer, Oncology

Read More →

Minorities Do Not Have Worse Outcomes In Dlbcl

]]>(MedPage Today) -- At the recent American Society of Hematology annual meeting, a single-center study showed that there were similar survival outcomes between Caucasians and non-Caucasians diagnosed with diffuse large B-cell lymphoma, despite...
Related topics: Medical Research, Lymphoma

Read More →

Fewer Steroids, Plasma Exchange For Anca-associated Vasculitis?

(MedPage Today) -- Study Authors: Michael Walsh, Peter A. Merkel, et al.; Vimal K. Derebail, Ronald J. Falk Target Audience and Goal Statement: Nephrologists, pulmonologists, hematologists, dermatologists, rheumatologists The goal of this study...
Related topics: Medical Research, Dermatology

Read More →

Hopes For New Von Willebrand Disease Trial

]]>(MedPage Today) -- At the recent 2019 American Society of Hematology annual meeting, a clinical trial was announced with an aim to determine whether intravenous recombinant von Willebrand factor (rVWF) is more effective than oral tranexamic...
Related topics: Clinical Trials

Read More →

Hematology-focused Biotech Imara To Ipo Soon

Imara, which is developing a drug for sickle cell disease and beta thalassemia, has set the terms for its initial public offering (IPO), with shares expected to sell for $16 to $18 each. The company could raise up to $80 million through the IPO,...

Read More →

First Complement-inhibition Study In Itp Is Promising

]]>(MedPage Today) -- Up to 20% of patients with immune thrombocytopenia (ITP) have inadequate responses to current therapy and remain at risk of life-threatening bleeds. In a study presented at the 2019 American Society of Hematology annual...
Related topics: Medical Research

Read More →

Car-nk Cells Hold Promise For Relapsed/refractory Leukemia And Lymphoma

(MedPage Today) -- Study Authors: Enli Liu, David Marin, et al. Target Audience and Goal Statement: Oncologists, hematologists The goal of this study was to assess the use of chimeric antigen receptor (CAR)-transduced natural killer (NK) cells...
Related topics: Leukemia, Lymphoma, Medical Research, Cancer, Oncology

Read More →

Early Combo Therapy With A Biologic More Effective In Jia

(MedPage Today) -- Study Authors: Bin Huang, Tingting Qiu, et al. Target Audience and Goal Statement: Rheumatologists, pediatricians, hematologists, radiologists The goal of this study was to compare the real-world effectiveness of early...
Related topics: Medical Research

Read More →

Impact Of Tp53 Mutation Clearance Prior To Allo-sct

]]>(MedPage Today) -- At the recent 2019 American Society of Hematology annual meeting, there were a number of presentations on targeted mutations, and one study out of Moffitt Cancer Center in Tampa, Florida, looked at the controversy regarding...
Related topics: Genetics, American Cancer Society, Medical Research, Cancer, Oncology

Read More →

Benefit Of Added Tnf Inhibitor In Very Early Ra Smaller Than Previously Thought

(MedPage Today) -- Study Authors: Paul Emery, Sarah Horton, et al. Target Audience and Goal Statement: Rheumatologists, radiologists, hematologists, primary care physicians The goal of this study was to determine if first-line etanercept, a...
Related topics: Medical Research, Cancer

Read More →

More Academic Success Found For Men Versus Women In Hematology

TUESDAY, Feb. 25, 2020 -- Men have more publications than women in hematology, regardless of whether women have caregiving responsibilities, according to a study published online Feb. 25 in Blood Advances. Allison A. King, M.D., M.P.H., Ph.D.,...
Related topics: Medical Research

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.